| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 20 |
| 1 | ASPIRIN 325 MG | 20 |
| 2 | ASPIRIN 81 MG | 20 |
| 3 | METHOTREXATE | 19 |
| 4 | METHOTREXATE SODIUM | 19 |
| 5 | GABAPENTIN | 17 |
| 6 | QUETIAPINE | 17 |
| 7 | OMEPRAZOLE MAGNESIUM | 16 |
| 8 | FUROSEMIDE | 15 |
| 9 | OMEPRAZOLE | 15 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEROPENEM-VABORBACTAM | 1 | 0.0200 |
| 1 | FOMEPIZOLE | 1 | 0.0053 |
| 2 | PENCICLOVIR | 1 | 0.0028 |
| 3 | THIOGUANINE | 4 | 0.0019 |
| 4 | CHORIONIC GONADOTROPIN | 1 | 0.0018 |
| 5 | NUSINERSEN | 13 | 0.0016 |
| 6 | ATRACURIUM BESYLATE | 1 | 0.0014 |
| 7 | POLYETHYLENE GLYCOL AND PROPYLENE GLYCOL | 1 | 0.0014 |
| 8 | FENOFIBRIC ACID | 1 | 0.0013 |
| 9 | MEBENDAZOLE | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 53 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 40 |
| 2 | Benzodiazepine [EPC] | 39 |
| 3 | Atypical Antipsychotic [EPC] | 28 |
| 4 | Mood Stabilizer [EPC] | 22 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 22 |
| 6 | Proton Pump Inhibitor [EPC] | 22 |
| 7 | Anti-epileptic Agent [EPC] | 20 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 20 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antisense Oligonucleotide [EPC] | 13 | 0.0011 |
| 1 | Anthelmintic [EPC] | 1 | 0.0003 |
| 2 | Oxytocic [EPC] | 1 | 0.0003 |
| 3 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 4 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 5 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 6 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 7 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 8 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 1 | 0.0002 |
| 9 | Contrast Agent for Ultrasound Imaging [EPC] | 1 | 0.0002 |